Phase 1 Safety Testing of SAR405838
by on Tuesday, July 10th, 2012 | No Comments
Condition: Neoplasm Malignant
Intervention: Drug: SAR405838
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Not yet recruiting – verified July 2012
See the article here: Phase 1 Safety Testing of SAR405838